Erik Atkisson's most recent trade in Rain Oncology Inc was a trade of 120,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 2, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Rain Oncology Inc | Erik Atkisson | General Counsel and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
Eiger BioPharmaceuticals Inc | Erik Atkisson | GC & Chief Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 26,750 | 26,750 | - | - | Stock Option (Right to Buy) | |
Eiger BioPharmaceuticals Inc | Erik Atkisson | GC & Chief Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) |